Price
Target price
€0.43
€0.43
2.370%
0.01
2.370%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for Relief Therapeutics Holding
sharewise wants to provide you with the best news and tools for Relief Therapeutics Holding, so we directly link to the best financial data sources.
Financials
News
MindMaze Therapeutics and Vibra Healthcare Announce Go-to-Market Partnership to Expand Commercial Footprint of Precision Neurotherapeutics in the U.S.
MindMaze Therapeutics and Vibra Healthcare Announce Go-to-Market Partnership to Expand Commercial Footprint of Precision Neurotherapeutics in the U.S.
MindMaze Therapeutics Publishes 2025 Annual Report and Corporate Update
MindMaze Therapeutics Publishes 2025 Annual Report and Corporate Update
MindMaze Therapeutics and Vibra Healthcare Announce Breakthrough RWE Results in High-Dose, High-Intensity Neurorehabilitation
MindMaze Therapeutics and Vibra Healthcare Announce Breakthrough RWE Results in High-Dose, High-Intensity Neurorehabilitation
MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank
MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank
MindMaze Therapeutics Appoints HealthTech Veteran Zach Henderson as CEO to Accelerate Global Commercial Scale
MindMaze Therapeutics Appoints HealthTech Veteran Zach Henderson as CEO to Accelerate Global Commercial Scale
MindMaze Therapeutics Provides Corporate Update and Publishes March 2026 Investor Presentation
MindMaze Therapeutics Provides Corporate Update and Publishes March 2026 Investor Presentation
MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics
MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
Relief Therapeutics and NeuroX Unveil Joint Presentation and Financial Outlook Ahead of Anticipated Business Combination
Relief Therapeutics and NeuroX Unveil Joint Presentation and Financial Outlook Ahead of Anticipated Business Combination
Relief Therapeutics Shareholders Approve Business Combination with NeuroX
Relief Therapeutics Shareholders Approve Business Combination with NeuroX